Palliative chemotherapy does not improve survival in metastatic esophageal cancer

Oncology

Volumn 79, Issue 1-2, 2010, Pages 46-54

  Adenis, Antoine ^a,b   Penel, Nicolas ^c,d   Horn, Samy ^b   Dominguez, Sophie ^b   Vanhuyse, Marie ^a,b   Mirabel, Xavier ^b  

^a UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^b Center Oscar Lambret   (France)

^c Department Medical Oncology ^*  (France)

^d UNIV LILLE   (France)

Author keywords

Chemotherapy; Esophageal cancer; Metastatic esophageal cancer; Palliative chemotherapy; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; SURVIVAL TIME;

EID: 78149289601     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318029     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global statistics, 2002. CA Cancer J Clin 2002; 55: 74-108.
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW: Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-1389.
3. Benhamiche AM, Colonna M, Aptel I, Launoy G, Schaffer P, Arveux P, et al: Estimation de l'incidence des cancers du tube digestif par région. Gastroenterol Clin Biol 1999; 23: 1040-1047
4. Mandard AM, Chasle J, Marnay J, Villedieu B, Bianco C, Roussel A, et al: Autopsy findings in 111 cases of esophageal cancer. Cancer 1981; 48: 329-335.
5. Anderson LL, Lad TE: Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 1982; 50: 1587-1590.
6. Bouvier AM, Binqueta C, Gagnaire C, Jouve JL, Faivre J, Bedenne L: Management and prognosis of oesophageal cancers: has progress been made? Eur J Cancer 2006; 42:228-233.
7. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, et al: Randomised phase II study of cisplatin and 5-fluorouracil versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 1997; 33: 1216-1220.
8. Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, et al: Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998; 16: 1826-1834.
9. Conroy T, Etienne PL, Adenis A, Ducreux M, Paillot B, Oliveira J, et al: Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 2002; 13: 721-729.
10. Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, et al: A phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 1999; 17: 3270-3275.
11. Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, et al: Phase II trial of oxaliplatin, leucovorin, and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol 2005; 16: 1320-1325.
12. Homs MY, v d Gaast A, Siersema PD, Steyerberg EW, Kuipers EJ: Chemotherapy for metastatic carcinoma of the esophagus and gastro- esophageal junction. Cochrane Database Syst Rev 2006; 4:CD004063.
13. Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg ME, Splinter TA, et al: Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatinbased combination chemotherapy. Br J Cancer 2003; 89: 2045-2050.
14. Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer - pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004; 22: 2395-2403.
15. Adenis L, Lefebvre JL, Cambier L: Registry of cancers of the upper respiratory and digestive tract at the Northern and Pas-de-Calais departments from 1984 to 1986. Bull Cancer 1988; 75: 745-750.
16. Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, et al: A phase II study of single-agent docetaxel in patients with metastatic oesophageal cancer. Ann Oncol 2004; 15: 955-959.
17. Lordick F, Lorenzen S, Al-Batran SE, Hofheinz R, Thuss-Patience PC, Porschen R, et al: Cetuximab and cisplatin/5-FU (CF) versus CF in first-line metastatic squamous cell carcinoma of the esophagus. A randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). 2008 ASCO Annual Meeting. J Clin Oncol 2008; 26 (suppl):abstr 4546.
18. Levard H, Pouliquen X, Hay JM, Fingerhut A, Langlois-Zantain O, Huguier M, et al: 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research. Eur J Surg 1998; 164: 849-857.